(Q57618520)

English

Selection of Active Drugs for Ovarian Cancer Based on CA-125 and Standard Response Rates in Phase II Trials

article

Statements

Selection of active drugs for ovarian cancer based on CA-125 and standard response rates in phase II trials (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit